English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A new magnetic graphene oxide (MGO) composite was developed as an adsorbent for the preconcentration of lenalidomide (LND) by ultrasound-assisted solid-phase extraction (UA-SPE) prior to determination by high-performance liquid chromatography with ultraviolet detection (HPLC-UV). The adsorbent was fabricated through chemical functionalization of a new surface-active ionic liquid (SAIL), i.e. 1-methyl-3-(trimethoxysilyl propyl)-imidazolium dodecyl sulfate (TMES-Im-DS) on MGO. The synthesized material presented the benefits of excellent adsorption for LND. The characterization of the synthesized functionalized magnetic nanocomposite was performed by Fourier transform-infrared spectroscopy, field emission scanning electron microscopy, Brunauer–Emmett–Teller (BET), vibrating sample magnetometry, and energy-dispersive X-ray spectroscopy. After optimization of the parameters, the limits of detection (LOD) and limit of quantification (LOQ) were 0.2 and 0.8 µg L −1  and 0.6 and 2.5 µg L −1 in water and plasma samples, respectively. The enrichment factors (EFs) were from 90 to 180 in the samples. The relative standard deviation (RSD%,  n  = 5) as intra- and inter-day precision were from 6.3% to 7.5% and 7.1% to 8.5% in water and plasma, respectively. Lastly, the developed method presented good results for the preconcentration of LND in plasma with satisfactory repeatability.

analytical letters

Magnetic Graphene Oxide Modified with a Surface-Active Ionic Liquid for Ultrasound-Assisted Solid-Phase Extraction (UA-SPE) to Preconcentrate Lenalidomide from Human Plasma with Determination by High-Performance Liquid Chromatography with Ultraviolet Detection (HPLC-UV)